Inventor
SCHIMMACK GISELA
DE11 patents
Patents
11 patentsUS11732021B2Aug 22, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11655281B2May 23, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11655280B2May 23, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11603397B2Mar 14, 2023
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US12227556B2Feb 18, 2025
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12202878B2Jan 21, 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12195516B2Jan 14, 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12084486B2Sep 10, 2024
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11779605B2Oct 10, 2023
Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11433099B2Sep 6, 2022
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12480958B2Nov 25, 2025
Method for the characterization of peptide:MHC binding polypeptides
IMMATICS BIOTECHNOLOGIES GMBH0 citations49